This week's digest covers regulatory changes impacting the medical device industry, from EU MDR certification to FDA actions, alongside manufacturing and technological advancements.

FDA Cracks Down on Chest Binder Manufacturers

The Gist:

The Challenge:

The FDA's decision to classify chest binders as medical devices has led to warning letters for multiple companies. The FDA's justification is that chest binders, which are designed to flatten the chest, are intended to affect the structure or function of the body. This has resulted in several companies, including TransGuy Supply and others, receiving these warning letters. The companies now face the regulatory burden of registering their products with the FDA. This reclassification has been met with criticism from the companies targeted. Concerns are raised that this may lead to restricted access and potential harm if consumers turn to unsafe alternatives or methods. Furthermore, the action is seen by some as part of a broader attack on transgender healthcare.

The Solution:

The companies are responding by updating their product language to indicate that their products are compression garments rather than medical devices. The FDA's actions are part of a larger federal effort to influence trans healthcare in America. Read more about this topic

Why This Matters:

This regulatory action could create significant challenges for manufacturers of compression garments. The reclassification of chest binders could increase compliance costs and administrative burdens, potentially forcing smaller companies out of business. It sets a precedent for how the FDA views gender-affirming products and could impact future regulatory pathways for similar devices. Companies may need to reassess their product labeling and marketing strategies, and potentially reformulate products to meet the new standards. The outcome could restrict access for transgender individuals. This situation requires a delicate balance between public safety and the needs of a vulnerable population.

New Tooling for Tiny Medical Devices

The Gist:

The Technical Breakdown:

Kennametal has developed specialized tooling systems for micromachining, the process of machining components at the micrometer level. The micromachining tools include solid carbide drills and micro boring bars, with new releases in diameters as small as 0.5mm. These tools have been designed with the medical industry in mind. Kennametal works directly with customers to develop designs for medical components, as well as the tools required to manufacture them. The use of micromachining requires tight tolerances and often involves difficult-to-machine materials, such as titanium and cobalt chrome. These require specialized coatings, and Kennametal uses PVD coatings for abrasion resistance and extended tool life. The company recently released new grades including carbides KCU10B and KCU25B as well as titanium grade KCS10B, all featuring new PVD coatings for better abrasion resistance and longer tool life. Read more about this topic

Why This Matters:

The shift towards micromachining has implications for design, manufacturing, and regulatory compliance. Design engineers will have more freedom. With precise tooling solutions, engineers can test and iterate designs more efficiently, potentially speeding up time-to-market. Manufacturing engineers will need to keep current with the latest tooling and manufacturing processes to ensure optimal production efficiency and precision. Device manufacturers will have to collaborate with tooling companies to meet the demands of advanced medical devices and ensure their products conform to industry standards. The industry could see improvements in implant designs and patient comfort as a result of these developments.

💬 Got thoughts on this week's stories?

Hit reply—I read every response. Or forward this to an engineer who'd appreciate it.

"Stay sharp, and keep those tolerances tight."